Osteoporosis Disease Management: What Every Orthopaedic Surgeon Should Know
- 1 November 2009
- journal article
- clinical trial
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of Bone and Joint Surgery
- Vol. 91 (Supplement), 79-86
- https://doi.org/10.2106/jbjs.i.00521
Abstract
There is a huge cost associated with osteoporosis in terms of morbidity, mortality, and the financial impact on society. The most devastating complication of osteoporosis is a hip fracture. According to the most recent statistics published in the United States Surgeon General's 2004 report on osteoporosis, of the 325,000 patients who sustain a hip fracture each year, 25% will find it necessary to enter a nursing home, 50% will never reach their previous functional capacity, and 25% will die within the first year after the fracture2. The first-year mortality rate after a hip fracture is almost twice as high in men as it is in women (30% compared with 17%). The mortality rate associated with osteoporosis-related fractures is greater than the rates associated with breast cancer and cervical cancer combined1-6.Keywords
This publication has 36 references indexed in Scilit:
- FRAX™ and the assessment of fracture probability in men and women from the UKOsteoporosis International, 2008
- Zoledronic Acid and Clinical Fractures and Mortality after Hip FractureThe New England Journal of Medicine, 2007
- Vitamin D DeficiencyThe New England Journal of Medicine, 2007
- Once-Yearly Zoledronic Acid for Treatment of Postmenopausal OsteoporosisThe New England Journal of Medicine, 2007
- Subtrochanteric insufficiency fractures in patients on alendronate therapyThe Journal of Bone and Joint Surgery. British volume, 2007
- Incidence and Economic Burden of Osteoporosis-Related Fractures in the United States, 2005–2025Journal of Bone and Mineral Research, 2007
- Osteonecrosis of the Jaw and BisphosphonatesThe New England Journal of Medicine, 2005
- Effect of Vitamin D on FallsJama-Journal Of The American Medical Association, 2004
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled TrialJama-Journal Of The American Medical Association, 2002
- Epidemiology and outcomes of osteoporotic fracturesThe Lancet, 2002